The VLW model of FTDP-17 presents with cortical and hippocampal alterations [150,151], epilepsy and hyperexcitability [152], resulting from overexpression of FTDP-17 human mutant tau in the absence of Aβ pathology. The gene discussed is MAPT; the disease is epilepsy.